Finally….. a cap raise to quieten the masses, and the price...

Finally….. a cap raise to quieten the masses, and the price moving back up. Who’d a thunk? For weeks we have been in a trading pattern of 5-7c with a blip after the FDA giving us the tick. It’s like there has been a relentless seller for reasons unknown, and they have now stopped. Maybe someone thought they could get the “obvious” soon to be available placement shares cheaper….Anyway, it seems over now, and the price is now moving up. to think we will be a clinical stage biotech after the first dose sometime soon…?next week perhaps, if not the week after, that should start to attract a new breed of investor, or at least get more peoples attention, especially the likes of the US players.

Once people realise this RP11 will make the company approx a billion in turnover and the next drug even more then the necessary SP adjustments will be made….